About

Patrick Anquetil, PhD, is Founder and Chief Executive Officer of Portal Instruments, leading a multidisciplinary team of engineers, scientists and business professionals dedicated to revolutionising injectable therapies with connected, reusable drug delivery solutions. His focus is on enhancing the patient experience and improving adherence to injectable therapies. With over 20 years of experience in the medtech and biotech industries, Dr Anquetil has a proven track record of innovation and strategic execution. Under his guidance, Portal has forged strategic partnerships with leading pharmaceutical companies, including Takeda, LEO Pharma and Sanofi, to integrate its cutting-edge technology into their combination products.

He has successfully raised over US$60 million (£45 million) in venture capital and non-dilutive funding, propelling Portal’s growth. Dr Anquetil holds a PhD in bio-instrumentation from the Massachusetts Institute of Technology (Cambridge, MA, US), an MBA from Harvard Business School (Boston, MA, US), and a master’s degree from ETH Zurich (Switzerland) and the University of Tokyo (Japan). His research has been published in peer-reviewed journals and featured in prominent outlets such as MIT Technology Review, Wired, PBS and CNBC.